"We have been constantly manufacturing Remdesivir since last month, and at our current capacity, we can supply 50,000 to 95,000 pieces of the injectable per month. We know how critical the situation is, especially with the pandemic still spreading across the country. Hence, we are in constant touch with all our clients, and ready to cater to any of their requirements with utmost priority.
Our manufacturing sites remain compliant with the highest global standards and certifications at all times, as it is our constant endeavour to cater to the ever-evolving requirements of the pharma industry. Even in such unprecedented times, we are proud that our facility has been able to supply this medication in record time to one of our key clients.
As Indian medical authorities and the pharma industry are working relentlessly to provide medications to treat Coronavirus, Sovereign Pharma has dispatched its first batch of Remdesivir injections for Cipla recently."
-Rishad Dadachanji, Director, Sovereign Pharma, Daman
